去定植与病原体减少策略预防抗菌药物耐药与医疗保健相关感染
医疗保健相关细菌病原体的抗菌药物耐药是重大公共卫生威胁;耐药菌感染可因临床扰动使定植菌增殖而发生,尤其当病原体抵抗抗菌药物的附带效应破坏微生物组、丧失定植抵抗时。病原体减少是预防耐药医疗保健相关病原体传播与感染的新兴策略,本文描述其依据、有效性证据、人类微生物组在定植抵抗中的作用,并探讨当前与未来病原体减少方法的理想属性。
要点
- 耐药菌感染可因临床扰动使定植病原菌增殖而发生。
- 抗菌药物破坏微生物组可丧失定植抵抗这一关键宿主防御。
- 病原体减少是预防耐药医疗保健相关病原体传播与感染的新兴策略。
核心结论
- 病原体减少是预防抗菌药物耐药医疗保健相关病原体传播与感染的新兴策略。
- 人类微生物组介导的定植抵抗可降低定植后感染风险。
研究设计与样本
- 本文描述病原体减少作为总体预防策略的依据、有效性证据及人类微生物组在定植抵抗中的作用。
- 本文探讨当前与未来病原体减少方法的理想属性。
主要发现
- 抗菌药物耐药细菌感染可发生于正常占人类微生物群小部分的定植病原菌因临床扰动而数量增加时。
- 当病原体抵抗抗菌药物破坏人类微生物组的附带效应时,定植抵抗丧失,感染尤其可能发生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial resistance in healthcare-associated bacterial pathogens and the infections they cause are major public health threats affecting nearly all healthcare facilities. Antimicrobial-resistant bacterial infections can occur when colonizing pathogenic bacteria that normally make up a small fraction of the human microbiota increase in number in response to clinical perturbations. Such infections are especially likely when pathogens are resistant to the collateral effects of antimicrobial agents that disrupt the human microbiome, resulting in loss of colonization resistance, a key host defense. Pathogen reduction is an emerging strategy to prevent transmission of, and infection with, antimicrobial-resistant healthcare-associated pathogens. We describe the basis for pathogen reduction as an overall prevention strategy, the evidence for its effectiveness, and the role of the human microbiome in colonization resistance that also reduces the risk for infection once colonized. In addition, we explore ideal attributes of current and future pathogen-reducing approaches.
引用
- Mangalea MR, Halpin AL, Haile M, et al. Decolonization and Pathogen Reduction Approaches to Prevent Antimicrobial Resistance and Healthcare-Associated Infections. Emerg Infect Dis. 2024. PMID: 38781679. doi:10.3201/eid3006.231338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。